Clinical Trials Logo

Clinical Trial Summary

This is a pilot study to assess barriers, evaluate and implement a patient oriented CIED management model incorporating advanced technological innovation to promote a paradigm shift to patient-centered care involving remote CIED monitoring and programming. The advancement in technology is very important as it addresses several potential gaps and barriers in the care of patients with CIEDS:

1. Long, expensive travel for patients

2. Morbidity to patients due to delay in receiving appropriate treatment

3. Efficiency in health care delivery

4. Patient satisfaction


Clinical Trial Description

Canada is a country with a diverse geography, of which 19% of the inhabitants are in communities classified as 'rural', but many may still have long distances to travel to reach a health care facility. This results in challenges in uniform delivery of health care throughout the country. There are 25,000 pacemaker (PM) implants and 7000 implantable defibrillator (ICD) implants yearly in Canada, with approximately 120 000 patients living with these devices. The recommended follow-up for these devices are based on consensus and position statements, with the majority of patients requiring at least yearly visits to a specialized device clinic during the lifetime of their device. During the life of these patients, many issues may arise, such as atrial or ventricular arrhythmias that may result in syncope, stroke or sudden death, need for increased monitoring resulting from device advisories, or minor programming adjustments to improve device performance, or simply the need for enhanced surveillance as the device battery depletes and replacement is anticipated.

While remote monitoring technology is currently available and has permitted surveillance and device assessment from any patient location accessible to a landline or mobile phone, the use has been inconsistent in Canada. In addition, new technology has become available that not only permits surveillance, but also remote programming of these devices. The incorporation of remote programming capability, along with automatic recalibration of device settings, allows us to develop a new paradigm of remote patient management where after the patient receives their device, they would remain in the care of their local health team and no longer require travel to the specialized 'hub' clinics for follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02585817
Study type Interventional
Source Nova Scotia Health Authority
Contact
Status Completed
Phase N/A
Start date October 2016
Completion date April 2019

See also
  Status Clinical Trial Phase
Completed NCT05563701 - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting NCT02988219 - Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method Phase 4
Suspended NCT03647891 - Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac Patients N/A
Recruiting NCT04345627 - Japanese Lead Extraction Registry
Completed NCT04076020 - Atrial Fibrillation Health Literacy and Information Technology Trial in Rural Pennsylvania Counties N/A
Terminated NCT03035227 - Catheter Ablation of Arrhythmias to Improve CRT Response Phase 4
Completed NCT02991716 - Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development N/A
Completed NCT03150030 - Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes
Recruiting NCT05437926 - A Study to Describe the Effectiveness of Arrhythmia Analysis Software for Screening of Sinus Rhythm, Atrial Fibrillation and Premature Beats in light-and Dark Skin Tone Patients
Completed NCT01956487 - Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites Phase 1